The new medical innovations:
Anktiva for Bladder Cancer: FDA Approved Immunotherapy That Avoids Chemotherapy
Anktiva (nogapendekin alfa inbakicept-pmln) is an FDA approved immunotherapy used with BCG for adults with BCG unresponsive non muscle invasive bladder cancer with carcinoma in situ (with or without papillary tumors). Instead of chemotherapy, this therapy is designed to activate the immune system, including natural killer cells, to help recognize and destroy cancer cells in the bladder.
First successful treatment for Huntington disease reported in new study
Huntington's disease has been treated for the first time using gene therapy, slowing progression by 75% after complex brain surgery, offering new hope for patients with this inherited neurodegenerative disorder.
Cancer rates among adults under 50 have risen worldwide over 30 years. The BBC Global Story podcast explores possible causes, affected cancers, and whether this trend can be prevented.